Dimensional Fund Advisors LP Sells 351,936 Shares of agilon health, inc. (NYSE:AGL)

Dimensional Fund Advisors LP trimmed its position in shares of agilon health, inc. (NYSE:AGL - Free Report) by 63.3% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 203,982 shares of the company's stock after selling 351,936 shares during the quarter. Dimensional Fund Advisors LP's holdings in agilon health were worth $1,334,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Vanguard Group Inc. raised its stake in agilon health by 1.3% during the first quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company's stock worth $176,582,000 after purchasing an additional 371,537 shares during the period. Capital International Investors grew its holdings in agilon health by 84.7% during the 1st quarter. Capital International Investors now owns 20,197,932 shares of the company's stock worth $123,207,000 after acquiring an additional 9,263,296 shares in the last quarter. Simplicity Wealth LLC lifted its position in shares of agilon health by 145.1% in the 2nd quarter. Simplicity Wealth LLC now owns 26,210 shares of the company's stock worth $171,000 after buying an additional 15,515 shares during the last quarter. Quantbot Technologies LP bought a new stake in agilon health in the 1st quarter valued at about $862,000. Finally, Seven Eight Capital LP bought a new stake in shares of agilon health during the 1st quarter worth about $1,593,000.

agilon health Trading Down 3.0 %

AGL stock traded down $0.10 during trading on Friday, hitting $3.22. The company had a trading volume of 3,053,318 shares, compared to its average volume of 4,966,783. The business has a 50-day moving average of $4.13 and a 200-day moving average of $5.31. agilon health, inc. has a one year low of $2.99 and a one year high of $20.37. The stock has a market cap of $1.32 billion, a PE ratio of -4.41 and a beta of 0.54. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 0.04.

agilon health (NYSE:AGL - Get Free Report) last issued its earnings results on Tuesday, August 6th. The company reported ($0.07) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.07). The company had revenue of $1.48 billion for the quarter, compared to analysts' expectations of $1.56 billion. agilon health had a negative return on equity of 29.91% and a negative net margin of 5.57%. agilon health's quarterly revenue was up 38.7% compared to the same quarter last year. During the same period last year, the business earned ($0.04) EPS. Research analysts predict that agilon health, inc. will post -0.32 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on AGL. Bank of America downgraded shares of agilon health from a "buy" rating to an "underperform" rating and set a $3.00 target price on the stock. in a research report on Wednesday, October 2nd. Evercore ISI dropped their target price on shares of agilon health from $7.00 to $4.00 and set an "in-line" rating on the stock in a research report on Tuesday, October 8th. Benchmark reissued a "buy" rating and issued a $9.00 price target on shares of agilon health in a report on Thursday, August 8th. Royal Bank of Canada reiterated an "outperform" rating and set a $8.00 price target on shares of agilon health in a research report on Wednesday, August 7th. Finally, Deutsche Bank Aktiengesellschaft cut their price target on shares of agilon health from $5.00 to $4.00 and set a "hold" rating on the stock in a research report on Friday, August 9th. Two equities research analysts have rated the stock with a sell rating, fourteen have issued a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $8.03.

Insider Activity

In related news, CEO Steven Sell bought 20,000 shares of the business's stock in a transaction on Thursday, September 12th. The stock was acquired at an average price of $3.36 per share, for a total transaction of $67,200.00. Following the purchase, the chief executive officer now directly owns 67,590 shares in the company, valued at $227,102.40. This trade represents a 0.00 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 3.20% of the company's stock.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.